MOH

Molina told investors in February that a Medicare drug plan serving tens of thousands of members would cease to exist. The members found out in October. Here is what that eight-month silence means for anyone still holding that plan card.

A task force led by Vance aims to remove 760,000 alleged fraudulent Obamacare enrollments, according to a WSJ exclusive.

Molina Healthcare’s stock fell to about $197.80 after recent weakness, with a 1.5% drop that day and a 7.6% decline over the week. The pullback follows a year of modest gains and a longer‑term decline in shareholder return.

Kopernik Global Investors recently released its “Global All-Cap Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund faced a difficult investment environment in the second quarter of 2026, as momentum-driven markets and soaring semiconductor stocks sharply favored growth-oriented equities over the fund’s value-focused approach.

Over the past 20 years, Molina Healthcare has outperformed the market with an average annual return of 11.61%, according to Benzinga.